Vertebrate Antibodies Limited in Aberdeen, AB24 2TZ

Websites

Zoom

vertebrateantibodies.com

Zoom

www.vertebrateantibodies.com

Description

Data updated on: 01-11-2023

Vertebrate Antibodies is a company with it's headquarters at AB24 2TZ Aberdeen at C/o Dr Steve Bird. This company has been in existence since 2011 and is registered under the identification number SC396954. This company has been operating on the British market for 14 years now and company current state is active. This firm known today as Vertebrate Antibodies Limited, was previously known as Pacific Shelf 1655. The change has occurred in 2011-07-20. This enterprise's registered with SIC code 72110 which means Research and experimental development on biotechnology. Vertebrate Antibodies Ltd released its latest accounts for the financial year up to 2022-04-30. The firm's most recent annual confirmation statement was released on 2022-11-07.

Considering the firm's size, it became necessary to acquire additional company leaders: Guofeng X., Abd A. and Ayham A. who have been collaborating since February 2023 for the benefit of the firm.

Previous company's names
Vertebrate Antibodies Limited 2011-07-20
Pacific Shelf 1655 Limited 2011-04-04

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-04-30	2013-04-30	2014-04-30	2015-04-30	2016-04-30	2018-04-30	2019-04-30	2020-04-30	2021-04-30	2022-04-30	2023-04-30	2024-04-30
Currency
Net Worth	101 950	115 605	119 030	132 864	117 209

Balance Sheet
Cash Bank On Hand						629	398	10 320	23 417	1 916	559 346	970 809
Current Assets	101 950	115 605	119 030	132 864	117 209	65 331	70 376	132 514	96 104	132 478	705 216	1 192 738
Debtors						64 702	69 978	106 594	12 303	60 441	70 511	167 570
Other Debtors						19 000	19 822	17 232	1 456	1 668	18 383	3 522
Property Plant Equipment										21 549	125 834	112 870
Total Inventories								15 600	60 384	70 121
Cash Bank In Hand	79 014	94 005	79 198	83 214	74 950
Net Assets Liabilities Including Pension Asset Liability	101 950	115 605	119 030	132 864	117 209
Stocks Inventory	18 705	21 600	39 832	49 650	42 259

Capital & Reserves
Called Up Share Capital	101 950	101 950	115 605	126 100	132 864
Profit Loss Account Reserve		13 655	3 425	6 764	-15 655
Shareholder Funds	101 950	115 605	119 030	132 864	117 209

Other Financial Data
Accrued Liabilities Deferred Income						19 389	10 665	12 569	41 646	42 708	11 379	9 000
Accumulated Amortisation Impairment Intangible Assets									5 316	14 275	26 057	37 839
Accumulated Depreciation Impairment Property Plant Equipment										1 649	11 597	39 329
Additions Other Than Through Business Combinations Intangible Assets								53 155	36 430
Amounts Owed To Group Undertakings											1 130 000	2 130 000
Average Number Employees During Period						5	5	8	9	5	6	6
Called Up Share Capital Not Paid						35 850	37 650
Corporation Tax Recoverable								19 417		43 789	52 128	129 542
Creditors						42 359	24 301	92 324	92 381	306 944	1 157 115	2 158 145
Deferred Income						22 970	13 636
Fixed Assets									84 269	125 309	217 982	193 236
Increase From Amortisation Charge For Year Intangible Assets									5 316	8 959	11 782	11 782
Increase From Depreciation Charge For Year Property Plant Equipment										1 649	9 948	27 732
Intangible Assets								53 155	84 269	103 760	92 148	80 366
Intangible Assets Gross Cost								53 155	89 585	118 035	118 205
Net Current Assets Liabilities	101 950	115 605	119 030	132 864	117 209	22 972	46 075	40 190	3 723	-174 466	-451 899	-965 407
Other Creditors									255	11 484	155	1 207
Other Remaining Borrowings								50 000	50 000	105 000
Other Taxation Social Security Payable									480	192	6 949	9 337
Prepayments Accrued Income						9 852	12 506	36 809	10 847	5 000
Property Plant Equipment Gross Cost										23 198	137 431	152 199
Total Additions Including From Business Combinations Intangible Assets										28 450	170
Total Additions Including From Business Combinations Property Plant Equipment										23 198	114 233	14 768
Total Assets Less Current Liabilities	101 950	115 605	119 030	132 864	117 209		46 075	93 345	87 992	-49 157	-233 917	-772 171
Trade Creditors Trade Payables								29 755		147 560	8 632	8 601
Trade Debtors Trade Receivables								33 136		9 984		34 506
Useful Life Intangible Assets Years									10
Number Shares Allotted		40 000		100 000	100 000
Par Value Share		3		0	0
Share Capital Allotted Called Up Paid	100 000	100 000	1 000	1 000	1 000

Role: Corporate Secretary

Appointed: 04 April 2011

Resigned: 08 July 2011

Address: Glasgow, G2 7EQ

Latest update: 14 May 2025

Roger C.

Role: Director

Appointed: 04 April 2011

Resigned: 08 July 2011

Latest update: 14 May 2025

People with significant control

The companies with significant control over this firm include: Epitogenx Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Cheltenham at Bayshill Road, GL50 3AT, Gloucestershire and was registered as a PSC under the reg no 14361802.

Epitogenx Limited

Address: Windsor House Bayshill Road, Cheltenham, Gloucestershire, GL50 3AT, United Kingdom

Legal authority Companies Act 2006

Legal form Private Limited Company

Country registered United Kingdom

Place registered Uk Register Of Companies

Registration number 14361802

Notified on 14 February 2023

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Mohamad S.

Notified on 3 January 2017

Ceased on 12 April 2019

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 January 2024
Account last made up date	30 April 2022
Confirmation statement next due date	21 November 2023
Confirmation statement last made up date	07 November 2022

Annual Accounts 25 April 2013
Start Date For Period Covered By Report	2011-04-04
End Date For Period Covered By Report	2012-04-30
Date Approval Accounts	25 April 2013
Annual Accounts
Start Date For Period Covered By Report	2012-05-01
End Date For Period Covered By Report	2013-04-30
Annual Accounts 19 March 2015
Start Date For Period Covered By Report	2013-05-01
End Date For Period Covered By Report	2014-04-30
Date Approval Accounts	19 March 2015
Annual Accounts 28 January 2016
Start Date For Period Covered By Report	2014-05-01
End Date For Period Covered By Report	2015-04-30
Date Approval Accounts	28 January 2016
Annual Accounts 30 January 2017
Start Date For Period Covered By Report	2015-05-01
End Date For Period Covered By Report	2016-04-30
Date Approval Accounts	30 January 2017
Annual Accounts
Start Date For Period Covered By Report	2018-05-01
End Date For Period Covered By Report	2019-04-30
Annual Accounts
Start Date For Period Covered By Report	2019-05-01
End Date For Period Covered By Report	2020-04-30
Annual Accounts
Start Date For Period Covered By Report	2020-05-01
End Date For Period Covered By Report	2021-04-30
Annual Accounts
Start Date For Period Covered By Report	2021-05-01
End Date For Period Covered By Report	2022-04-30
Annual Accounts
Start Date For Period Covered By Report	2022-05-01
End Date For Period Covered By Report	2023-04-30
Annual Accounts
Start Date For Period Covered By Report	2023-05-01
End Date For Period Covered By Report	2024-04-30
Annual Accounts 28 March 2014
Date Approval Accounts	28 March 2014

Vertebrate Antibodies Limited

General information

Name:

Office Address:

Contact information

Websites

vertebrateantibodies.com

www.vertebrateantibodies.com

Description

Financial data based on annual reports

Company staff

Guofeng X.

Abd A.

Ayham A.

Steve B.

Ann L.

Hilda C.

Mohamed S.

David M.

Md Secretaries Limited

Roger C.

People with significant control

Epitogenx Limited

Mohamad S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies